Fresenius Kabi Receives 2026 Vizient Pharmacy Strategic Programs Excellence Award
Fresenius Kabi, part of global healthcare company Fresenius, has received the 2026 Pharmacy Strategic Programs Excellence Award from Vizient, a provider-driven healthcare performance improvement company in the United States.
The award recognizes Fresenius Kabi’s work supporting healthcare providers in efforts to improve pharmacy performance, optimize costs and quality, strengthen market performance and build greater resilience across the healthcare supply chain.
The recognition was announced on September 22, 2026, during an awards ceremony held at the Vizient Connections Summit in Las Vegas. The annual event brings together healthcare organizations and industry stakeholders to discuss strategies for improving clinical, operational and financial performance across the healthcare system.
For Fresenius Kabi, the award highlights its work with Vizient provider clients and its focus on supporting reliable access to medicines while helping healthcare organizations manage the operational and financial challenges associated with pharmaceutical procurement.
Recognizing Pharmacy and Supply Chain Performance
Pharmacy departments play an important role in healthcare delivery, with responsibilities extending from medication selection and procurement to inventory management, patient care and cost optimization.
Healthcare providers also operate in an environment where supply chain disruptions, pricing pressures and changes in demand can affect the availability and affordability of medicines. As a result, hospitals and health systems increasingly look for strategies that can support both high-quality patient care and sustainable pharmacy operations.
Vizient’s Pharmacy Strategic Programs Excellence Award recognizes organizations that help provider clients address these challenges.
According to Vizient, Fresenius Kabi’s recognition reflects the company’s efforts to empower healthcare providers to optimize pharmacy costs and quality while strengthening their overall market performance and supply chain capabilities.
The award therefore extends beyond individual pharmaceutical products. It recognizes the broader relationship between suppliers and healthcare organizations and the role that pharmaceutical manufacturers can play in supporting providers’ operational priorities.
“Congratulations to Fresenius Kabi on receiving the 2026 Pharmacy Strategic Programs Excellence Award,” said Simrit Sandhu, president, spend management, Vizient. “This recognition reflects the company’s commitment to supporting Vizient clients as they work to optimize pharmacy performance, manage costs and strengthen the healthcare supply chain.”
Supporting Healthcare Providers
Vizient works with a broad range of healthcare organizations across the United States. Its client base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers.
These organizations vary considerably in size, structure and patient population, but they share the need to maintain reliable access to medicines and other healthcare resources while managing financial and operational requirements.
For pharmacy leaders, managing medication costs is one part of a much larger responsibility. They must also consider product availability, quality, inventory requirements, clinical needs and the continuity of supply.
Fresenius Kabi’s relationship with healthcare providers is centered on pharmaceutical and healthcare products and services, making supply reliability an important part of its engagement with hospitals and other care organizations.
The company said its goal is to help ensure a sustainable supply of medicines so healthcare providers can continue delivering patient care.
“We’re honored to be recognized by Vizient for our service record with their providers,” said Arun Verma, president, Fresenius Kabi Region U.S. and member of the Executive Leadership Team, Fresenius Kabi AG.
“Our goal is always to assure a long-term, sustainable drug supply so providers can provide the highest quality of care,” Verma added.
Focus on Sustainable Drug Supply
A reliable pharmaceutical supply chain is an important component of healthcare system operations. Hospitals depend on manufacturers and distributors to maintain access to medicines required for routine treatment as well as more complex clinical situations.
Supply interruptions can create additional challenges for pharmacy teams, potentially requiring alternative products, changes in procurement strategies or additional inventory planning.
Against this backdrop, manufacturers that can support predictable and sustainable supply can provide value beyond the individual medicines they produce.
Fresenius Kabi’s award from Vizient reflects this broader focus. The company said its objective is to work with healthcare providers to support long-term access to medicines while helping organizations address cost and quality considerations.
The emphasis on sustainability is particularly relevant to pharmacy leaders responsible for balancing financial constraints with patient-care requirements. A long-term approach to supply can help organizations plan procurement and inventory needs while reducing uncertainty around medication availability.
Pharmacy Performance and Cost Management
Pharmacy spending represents a significant component of healthcare costs. Hospitals and health systems therefore continually evaluate ways to manage pharmaceutical expenditures while maintaining access to therapies required by patients.
Cost management can involve multiple factors, including purchasing strategies, product selection, inventory management and supply continuity.
Vizient’s recognition of Fresenius Kabi highlights the company’s role in helping provider organizations navigate these issues.
The Pharmacy Strategic Programs Excellence Award is specifically focused on programs and partnerships that contribute to pharmacy performance. Fresenius Kabi’s recognition indicates that its work with Vizient’s provider clients has supported efforts involving cost optimization, quality and supply chain management.
Rather than viewing cost and quality as separate priorities, healthcare organizations increasingly seek approaches that address both. A lower-cost product may not provide an overall operational benefit if availability is inconsistent, while a reliable supply may need to be balanced against budget requirements.
The relationship between pharmaceutical manufacturers and healthcare providers can therefore be important in developing sustainable procurement strategies.
Strengthening the Healthcare Supply Chain
Healthcare supply chains have faced increased attention in recent years as hospitals and health systems seek greater resilience and predictability.
Pharmaceutical supply chains can be particularly complex because they involve manufacturers, distributors, group purchasing organizations, pharmacies, hospitals and other healthcare providers. Maintaining continuity requires coordination across multiple participants.
Fresenius Kabi’s recognition from Vizient reflects its stated focus on supporting this ecosystem.
The company is part of Fresenius, a global healthcare organization, and Fresenius Kabi focuses on medicines and healthcare products used in a range of clinical settings.
Through its U.S. operations, Fresenius Kabi works with healthcare providers across the country. The company’s engagement with Vizient and its provider clients provides another avenue through which it can support healthcare organizations seeking to manage pharmacy performance and supply requirements.
Recognition at Vizient Connections Summit
The award was presented during the Vizient Connections Summit in Las Vegas on September 22, 2026.
The summit provides an opportunity for healthcare leaders and industry participants to discuss healthcare performance improvement and strategies for addressing challenges facing providers.
Fresenius Kabi’s recognition at the event places its pharmacy and supply chain efforts within this broader industry discussion.
The award also highlights the importance of collaboration between healthcare providers and pharmaceutical suppliers. Hospitals and health systems rely on manufacturers not only for medicines but also for consistent supply and engagement around operational needs.
For Fresenius Kabi, the recognition represents acknowledgment from Vizient of the company’s service to provider organizations.
A Broader Commitment to Healthcare Delivery
The award comes as healthcare organizations continue to seek ways to improve operational efficiency while maintaining high standards of patient care.
Pharmacy teams are central to this effort. They manage medications that are essential to patient treatment while also dealing with procurement, inventory, budgets and supply continuity.
Manufacturers can support these efforts by maintaining dependable supply, working collaboratively with healthcare organizations and understanding the operational challenges faced by providers.
Fresenius Kabi said its objective is to maintain a long-term and sustainable drug supply. The company views reliable availability as an important component of helping providers deliver quality care.
Verma’s comments underscore this connection between supply and patient outcomes. By supporting consistent access to medicines, pharmaceutical companies can contribute to the ability of healthcare organizations to maintain treatment services.
Recognition for Provider-Focused Service
The 2026 Pharmacy Strategic Programs Excellence Award adds to Fresenius Kabi’s recognition for its engagement with healthcare providers through Vizient.
The award specifically acknowledges efforts that support pharmacy performance, cost management and healthcare supply chain strength. It also reflects the growing importance of provider-manufacturer collaboration as healthcare organizations navigate financial pressures and operational complexity.
For Vizient, recognizing Fresenius Kabi highlights a supplier relationship that it says has helped its provider clients pursue pharmacy-related performance goals.
For Fresenius Kabi, the award provides external recognition of its approach to working with healthcare organizations and its emphasis on maintaining a sustainable medicine supply.
As hospitals, health systems and other healthcare providers continue to balance patient-care priorities with financial and supply chain challenges, pharmaceutical manufacturers remain an important part of the broader healthcare delivery ecosystem.
Fresenius Kabi’s recognition at the 2026 Vizient Connections Summit highlights that relationship and the role of pharmaceutical supply reliability in supporting provider operations.
The company said it will continue focusing on its long-term objective of helping ensure sustainable access to medicines so healthcare providers can maintain the quality of care delivered to patients.
About Fresenius Kabi
Fresenius Kabi is part of the global healthcare company Fresenius and specializes in lifesaving medicines, medical technologies, and services for critically and chronically ill patients. With more than 41,000 employees and present in over 100 countries, Fresenius Kabi’s broad portfolio enables access to high-quality products across emergency medicine, surgery, oncology, intensive care, and at home – reaching around 450 million patients each year.
Through complementary business areas, Fresenius Kabi offers highly complex biopharmaceuticals for the treatment of cancer, autoimmune and endocrine diseases; leading enteral, parenteral and homecare solutions within medical nutrition; innovative medical technology including infusion pumps, cell and gene therapy devices, disposables and blood collection systems; and intravenous generic drugs and fluids that are vital to the work of healthcare providers globally.
For more information, please visit www.fresenius-kabi.com.
About Fresenius
Fresenius (XFRA: FRE, OTC: FSNUY) is a global, therapy-focused healthcare company dedicated to saving and improving human lives around the world. Through Fresenius Kabi and Fresenius Helios, the company delivers system-critical, innovative and affordable healthcare across the full continuum of care: Fresenius Kabi is a leading provider of lifesaving medicines, clinical nutrition, and medical technologies for critically and chronically ill patients, reaching around 450 million people each year. Fresenius Helios is Europe’s largest private hospital operator, treating around 27 million patients annually.
With more than 178,000 employees and operating in more than 60 countries, Fresenius generated €22.6 billion in revenue in 2025.